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Introduction
Systematic reviews and meta-analyses of the effectiveness of 
stroke rehabilitation interventions form a valuable resource 
for stroke survivors, carers, researchers, health-care 
professionals, guideline developers, and policymakers. The 
Cochrane Library1 contains over 200 stroke-related systematic 
reviews coordinated by the Cochrane Stroke Review Group. 
The influential role of systematic reviews as the primary 
route to readily accessible and rigorous summaries of stroke 
trial findings confers a responsibility on reviewers to 
implement valid and robust methodology. With the rapid and 
accelerating accumulation of new stroke trial data, systematic 
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Abstract
Objective: Continuous outcome measures are essential in rehabilitation research. Incomplete reporting of their mean 
and standard deviation, required for meta-analysis, potentially introduces bias and imprecision if it prevents studies being 
included. We aimed to determine how often systematic reviewers encounter missing mean or standard deviation values and 
to recommend practical statistical solutions.
Design: 1. Cross-sectional survey of systematic review authors. 2. Reanalysis of Cochrane review data to evaluate how 
accurately statistical methods for recovering missing mean or standard deviation values estimate the true meta-analysis 
treatment effect.
Setting: Rehabilitation intervention systematic reviews. 
Participants: Cochrane stroke rehabilitation review authors; stroke patients.
Interventions: Reanalysis of a Cochrane review of early supported discharge services.
Main measures: Hospital length of stay.
Results: Survey responses covered 53 of 70 Cochrane reviews.  Almost all studied continuous outcome measures, 68% 
encountering missing summary statistics. Various solutions were attempted but 76% of meta-analyses omitted at least one 
study due to missing information.  In the review reanalysis (N = 1055), a method based on the minimum and maximum 
performed best in recovering missing standard deviations; a method based on the median, lower and upper quartiles 
successfully estimated a missing mean.
Conclusion: Practical statistical methods help reduce risk of bias, maximise the evidence included in rehabilitation meta-
analyses and offer a clear hierarchy of solutions to handling unreported mean and standard deviation values.
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reviews must summarize the evidence with minimal bias and 
the greatest possible precision to inform stroke patients and 
health care professionals and to guide future stroke research. 
This depends critically on avoiding bias in identifying trials, 
selecting trials for meta-analysis, and extracting data;2 and on 
including as much of the available data as possible. 
Continuous outcome measures, such as the Stroke 
Impact Scale3 and stroke-specific quality of life (SS-
QOL)4 are highly relevant to stroke survivors, while 
continuous resource use measures such as hospital length 
of stay are pivotal to evaluating the cost-effectiveness of 
a stroke intervention. Around one-third of stroke reviews 
in the Cochrane Database of Systematic Reviews1 include 
a continuous primary outcome; three-quarters contain a 
continuous secondary outcome.
Although some continuous outcomes have a “bell-
shaped” normal distribution, many do not; examples include 
hospital length of stay and measures of physical function 
and poststroke depression.5 For such outcomes, analysis 
strategies and reporting vary6: the clinical trial publication 
often summarizes the outcome using the median and either 
the minimum and maximum values or the lower and upper 
quartiles. In contrast, standard meta-analysis requires 
information on the mean and either the standard deviation, 
variance or standard error7 for each treatment group. These 
may not be reported for outcomes that are not normally 
distributed. Accessing original individual patient data or 
additional summary statistics not included in the original trial 
report is often difficult.8 
While the problem of incomplete reporting of trials9 
has lessened in recent years thanks in part to reporting 
guidance, such as the consolidated standards of reporting 
trials (CONSORT),10 in order to summarize the available 
literature, fully stroke rehabilitation systematic reviewers 
still need to deal with unreported standard deviation and 
mean values. One option is to exclude the trial from the 
meta-analysis. The alternative is to apply statistical methods 
to recover the unreported values, allowing the trial to be 
retained in the meta-analysis. We recently reviewed methods 
to handle missing standard deviation and missing mean 
values.11 Here, we explore the extent of the issue in stroke 
rehabilitation systematic reviewing and illustrate potential 
solutions by reanalyzing individual patient data from the 
Cochrane stroke review.12
We planned to establish, via a survey of the authors of 
Cochrane reviews, how often stroke rehabilitation systematic 
reviewers encounter missing mean or standard deviation 
values in their reviews and the methods they use to address 
this. Second, we aimed to illustrate the use of statistical 
methods for handling missing standard deviation and mean 
values in meta-analysis by reanalyzing individual patient 
data from a Cochrane stroke review.12 We sought to identify 
methods that would be straightforward for systematic 
reviewers to apply, while still avoiding bias and giving the 
correct level of precision in the meta-analysis findings.
Methods
Survey Design
We performed an online survey of all authors who published 
a Cochrane review of a stroke rehabilitation intervention. A 
covering email (Figure S1) explained the background to the 
research and the questionnaire objectives. Completion of the 
questionnaire was voluntary, the results being held 
confidentially and used for research purposes only. The 
covering email contained a link to the online Google Forms 
questionnaire; for invitees based in China, where Google 
Forms was inaccessible at the time of the survey, the 
questionnaire was attached to the email. The questionnaire 
may be viewed at https://docs.google.com/forms/d/18Ph7 
WdaPFVz3eETtDjSRAmVjYwLng5PFB_JvrQLI3Z0/edit. 
The Ethics Review Committee of University of Edinburgh, 
Centre for Population Health Sciences, approved the study.
Stroke rehabilitation review authors were invited to 
complete the questionnaire within 1 month; if no response 
was received a single reminder e-mail was sent. Completion 
of the questionnaire was considered an indicator of consent. 
The online questionnaire was piloted by 4 authors of 
Cochrane reviews before circulating it to the full list of 
potential participants.
Survey Sample Size and Data Analysis
At the time of the survey (November 2015-March 2016) there 
were 70 published Cochrane Stroke Reviews of rehabilitation 
interventions. For each rehabilitation review the lead author, 
the second author and the contact author were approached. 
Authors of more than one published review were asked to 
complete one questionnaire per review. 
Questionnaire data were summarized using frequencies 
and percentages to indicate the extent of missing mean and 
standard deviation data in rehabilitation reviews and how 
reviewers dealt with this. 
Statistical Methods for Handling Missing Standard 
Deviation or Mean Missing Standard Deviation
In a methodology systematic review,11 we identified 15 
methods for handling missing standard deviation values. We 
selected for further evaluation, 2 of which are readily 
applicable and which do not require complex statistical 
modeling. First, Walter and Yao13 present an enhancement to 
the range method based on the minimum and maximum 
observed values of the outcome, providing a look-up table of 
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conversion factors from range to standard deviation for 
various sample sizes. Secondly, Ma et al14 present a study-
level imputation method which uses the weighted average of 
the variances observed in other trials in the meta-analysis. In 
addition to these 2 methods, the Cochrane Handbook7 notes 
that (for a normally distributed outcome measure) the 
interquartile range (IQR) approximately equals to 1.35 
standard deviations; we also evaluated this method as it is 
similar to another approach15 identified in our review. 
Hereafter, we refer to these approaches as enhanced range, 
weighted average, and IQR methods, respectively.
Missing Mean
Our systematic review of methods for handling missing mean 
values11 identified 4 approaches. From these, we chose for 
detailed assessment 3 pragmatic methods15-17 that estimate the 
mean algebraically based on other summary statistics that are 
likely to be reported. Ho et al16 derive a missing mean value 
using the median, minimum, maximum (MMM), and sample 
size. Bland17 takes account of the extended scenario where 
information on the lower and upper quartiles is also available 
(MMMQ1Q3); Wan et al15 provide a method which applies 
where the median and lower and upper quartiles are available 
but the minimum and maximum are not (MQ1Q3).
The Appendix includes formulae and reference to an 
online calculator for the methods for replacing missing 
standard deviation or mean values.
Data Source
Data were from trials of early supported discharge services 
following acute stroke included in a Cochrane systematic 
review and individual patient data meta-analysis.12 The data 
were from 8 trials (1055 participants). From this we generated 
example meta-analyses when the standard deviation or mean 
value was unavailable. We illustrated statistical methods for 
recovering the standard deviation when it was missing from 
both intervention arms for each of the 8 trials in the data set 
in turn. An equivalent approach demonstrated methods for 
handling missing mean values. 
Evaluation of Statistical Methods
We evaluated each statistical method for estimating missing 
standard deviation or mean values compared to analysis of 
the complete data set using the following:
1. The bias of the overall meta-analysis result (the dif-
ference between the estimated and true values of the 
intervention effect).
2. The precision of the overall meta-analysis result (the 
ratio of the widths of the confidence intervals for the 
intervention effect [width when estimating missing 
standard deviation or mean: width when complete 
data set analyzed]); values greater than 1 indicate 
worse precision than under the analysis of the com-
plete data set.
Method performance was judged overall by combining the 
bias and precision to calculate the mean squared error which 
was then compared to the mean squared error from analysis 
of the complete data set. 
We also investigated the performance of the default 
option of omitting a trial with missing standard deviation 
or mean value(s) from the meta-analysis.  Findings were 
illustrated graphically by presenting the overall meta-analysis 
results (intervention effect and 95% confidence interval) for 
each of the methods alongside the complete data set analysis 
result and the result where the trial with a missing standard 
deviation or mean value was omitted.
We analyzed hospital length of stay, an outcome with 
a skewed distribution for which the standard deviation and 
mean summary statistics may be more likely to be omitted 
from published trial reports. The intervention effect on 
hospital length of stay was estimated by the mean difference 
using random effects meta-analysis models fitted in the 
Cochrane RevMan software v5.3.18
Results
Survey
Figure 1 summarizes the online questionnaire findings. The 
survey was sent to 100 authors, based in 11 countries, of 70 
Cochrane reviews of a stroke rehabilitation intervention. 
Around 63 responses (53 reviews, 76%) were received.  Most 
respondents (58 of 63; 92%) knew the details of the analyses 
performed in their review; 56 reviewers had aimed to analyze 
continuous outcomes. Also, 89% (51 of 56) had intended to 
extract the mean, standard deviation, and sample size in the 
review; unreported standard deviations or means were 
encountered by 68% (38 of 56). Meta-analysis was often 
performed in situations where missing standard deviations or 
means had been encountered (34 of 38; 89%).
Of the reviewers who attempted meta-analysis, having 
encountered unreported standard deviation or mean values, 
the majority contacted source trial publication authors to 
request the missing items (29 of 34; 85%).  While some 
received all of the information requested, including 3 who 
were sent the original trial data, many (50%) obtained less 
than half of the information they requested or did not receive 
a response. Many review authors (62%) also used statistical 
imputation to estimate the unreported values. Despite 
these various strategies, most authors (26 of 34; 76%) who 
encountered unreported standard deviation or mean values 
had to omit at least one trial from their meta-analysis.
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Figure 1. Online Survey
Example Review Reanalysis 
We tested various strategies for dealing with missing data 
using the Cochrane review of early supported discharge.12
Missing Standard Deviation 
Figure 2(a) summarizes the performance of the enhanced 
range, weighted average, and IQR methods for replacing 
missing standard deviation values in meta-analysis. Detailed 
assessment of the bias and precision of methods is presented 
in online supplementary Table S1. All 3 methods performed 
consistently better than the strategy of omitting the trial with 
missing standard deviation from the meta-analysis which 
biased the true treatment effect estimate (9.36 days) by up to 
2 days. While differences between statistical methods were 
small, the enhanced range approach showed least bias. A 
Figure 2. Comparison of Methods for Handling (a) Missing 
Standard Deviation and (b) Missing Mean Values
Notes. Intervention effect (mean difference in length of stay, early supported 
discharge minus usual care) and its 95% confidence interval from random 
effects meta-analysis. Methods for handling missing standard deviation are 
(a) analyze complete data set (b) WA, weighted average, (c) ER, enhanced 
range, (d) IQR, and (e) omit study with missing standard deviation from 
meta- analysis. Results for WA, ER, IQR, and “omit study” are for scenarios 
where the standard deviation was considered to be missing from each of 
the 8 trials in the meta-analysis in turn. Methods for handling missing mean 
are (a) analyze complete data set, (b) MMM, (c) MQ1Q3MM, median/lower 
quartile/upper quartile/minimum/maximum, (d) MQ1Q3, median/lower 
quartile/upper quartile, and (e) omit study with missing mean from meta-
analysis. Results for MMM, MQ1Q3MM, MQ1Q3, and “omit study” are for 
scenarios where the mean was considered to be missing from each of the 8 
trials in the meta-analysis in turn.
similar pattern was found for imprecision; omitting the trial 
gave poorer precision and the enhanced range method nearly 
always performed the best. Overall, the enhanced range gave 
an MSE closest to that obtained from analysis of the complete 
data set in 7 of the 8 scenarios.
Missing Mean
Figure 2(b) and supplementary Table S2 provide the 
corresponding results when replacing a missing mean value 
was required. The MQ1Q3MM and MQ1Q3 methods 
provided less biased results than the MMM or trial omission 
strategies. Overall the MQ1Q3 approach had an MSE closest 
to that obtained from the analysis of the complete data set in 
most scenarios, providing a substantially superior MSE in 2. 
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1: Use algebraic recalculation to 
recover missing mean or 
standard deviation 
2: Contact study authors to 
request mean, standard 
deviation or trial data 
3: Use approximate algebraic 
calculations   
If required information for
this unavailable in trial report  
If authors do not provide
source trial data or relevant
summary measures  
For missing standard 
deviation: use enhanced  
range method   
For missing mean: use
MQ1Q3 method   
If required summary
statistics not reported, use
IQR or weighted average
method for missing standard
deviation; and MMM method
for missing mean  
 
 
 
Figure 3. Recommended Steps to Handle Missing Mean or 
Standard Deviation Values
Note. The aim is to select the approach as near to the top of the flowchart 
as possible according to data availability. For step 3, highlighted in red, based 
on our mean squared error findings we recommend the enhanced range14 
method for missing standard deviation and MQ1Q316 for missing mean. 
Where the summary statistics required by these methods are unavailable, we 
recommend use of alternative methods7,15,17,18 as appropriate. Approximate 
algebraic approaches will be readily implementable by most systematic 
reviewers. If these are unavailable, more specialist statistical approaches 
such as those recommended in Wiebe et al21 will be required but stroke 
systematic reviewers may find these less feasible to implement.
Recommendations
Figure 3 illustrates an overall stepwise strategy that enables 
stroke systematic reviewers performing meta-analysis to 
handle mean or standard deviation summaries that are missing 
from clinical trial reports.
Discussion
Our questionnaire findings demonstrate that missing summary 
statistics pose a problem for systematic reviewers in stroke 
rehabilitation studies, and that there is a lack of consensus 
over how best to address the issue. This paper has highlighted 
methods that reviewers may readily apply to estimate 
unreported mean or standard deviation values. In tests, using 
real data from the Cochrane review of early supported 
discharge interventions following stroke, the enhanced range 
method13 proved particularly reliable in estimating a missing 
standard deviation and the MQ1Q3 method15 performed 
strongly in estimating an unreported mean. As a supplement to 
the guidance on handling missing data already available in the 
Cochrane Handbook,7 these methods will help review authors 
maximize the information included in meta-analyses.  
Strengths and Limitations
Inviting multiple authors from each review to comment and 
asking detailed questions about the methods used ensured 
that we obtained comprehensive information on the 
approaches currently being used by systematic reviewers of 
stroke rehabilitation interventions to deal with missing 
summary statistics, at a level of detail not available in the text 
of review publications. The use of individual participant data 
from the real Cochrane review demonstrated that the 
analytical strategies are straightforward to apply and perform 
strongly in minimizing bias and optimizing the precision of 
the meta-analysis estimates.
Our survey of Cochrane’s review authors was restricted 
to stroke rehabilitation-intervention reviews, further 
investigation is required to confirm whether the findings 
are also reflected in other systematic review topics. Our 
questionnaire was limited to the English language. Although 
some review authors did not have English as their first 
language, all had recently published academic articles in 
English so we did not anticipate any language barriers.  
While our early supported discharge review reanalysis 
showed consistent performance of methods in a review 
where a strong treatment effect is present on the length of 
stay outcome, the findings here relate to analysis of a single-
exemplar data set. However, the early supported discharge 
services analysis contained a typical number of trials, of 
a representative size, for a stroke systematic review. A 
separately published analysis11 in which meta-analysis data 
sets were generated using individual participant data from 
the general anesthesia versus local anesthesia (GALA) 
trial19 showed similar findings, notably across meta-analyses 
ranging from 5 to 30 included trials and covering small (<25), 
large (>80) or mixed numbers of participants per trial.
Generalizability
Do these findings generalize to other stroke trial contexts 
and indeed to other therapeutic areas? We deliberately 
selected stroke rehabilitation as an area in which the 
continuous outcomes measures used may well have a skewed 
distribution and therefore would be prone to unreported 
mean or standard deviation values. Nonetheless, work in the 
surgical context19 supports the findings and certain outcomes, 
such as length of hospital stay, will not be normally 
distributed whether the context is acute, subacute or 
rehabilitation. More generally, the practical information 
(Appendix) on implementing the statistical approaches 
outlined in this paper mean that the methods will be readily 
applied in reviews in any therapeutic indication.
Conclusion
Incomplete reporting of trial findings is likely to reduce over 
time, thanks to initiatives to improve reporting, such as the 
CONSORT.20 In the meantime, our questionnaire findings 
will raise awareness among journal editors and systematic 
reviewers of the important issue of unreported mean and 
6 Journal of Stroke Medicine
standard deviation values, while the methods highlighted in 
this paper will help reviewers to satisfy the ongoing ethical 
obligation to make effective use of data from trials that have 
already completed.
Clinical Messages
 • Rehabilitation outcome measures which are 
important to patients and researchers often have a 
skewed (non-normal) distribution. As a consequence, 
authors of systematic reviews of rehabilitation 
interventions are likely to encounter missing mean 
or standard deviation values in clinical trial reports.
 • Practical statistical methods are available to help 
reviewers replace missing summary statistics, 
allowing them to include more of the eligible trials 
in their reviews and, hence, reducing the risk of bias 
in the results of meta-analysis.
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Figure S1. Survey Invitation Letter  
Table S1. Test Review Reanalysis: Missing Standard Deviation
Table S2. Test Review Reanalysis: Missing Mean
Appendix: Resources for Recovering Missing 
Standard Deviation and Mean Values
Missing Standard Deviation: Enhanced Range
Walter and Yao13 provide a lookup table based on the minimum, 
maximum and sample size.
Missing Standard Deviation: Weighted Average14
Either use the smallest and largest standard errors reported for 
other studies in the meta-analysis to provide best- and worst-case 
scenarios; or use a weighted average of the observed standard errors 
in other studies in the meta-analysis.  The weighted average formula 
is SEM
SEM n
k n
j
i
k
i i
j
*
*
=
=
∑ 1  where SEM j* is the standard error for the 
study with the missing standard deviation, nj
* is the sample size of 
that study, SEMi are the standard errors observed in the other studies 
in the meta-analysis, ni are the sample sizes of the other meta-anal-
ysis studies, and k is the number of other trials in the meta-analysis 
which reported a standard error.
Missing Standard Deviation: IQR7
If lower (Q1) and upper (Q3) quartiles are reported replace the 
missing standard deviation by: (Q3 − Q1)/1.35.
Missing Mean: MMM16
If the median M, minimum A, maximum B and sample size n are 
known, the missing mean x is estimated by:
x
A M B A M B
n
≈
+ +
+
− +2
4
2
4
Missing Mean: MQ1Q3MM17
If the median M, lower (Q1) and upper (Q3) quartiles, minimum A, 
maximum B and sample size n are reported, use:
x
n A n Q M Q M n B
n
≈
+( ) + −( ) + +( ) + +( )3 2 1 1 3 3
8
Missing Mean: MQ1Q315
Where the median M, lower (Q1) and upper (Q3) quartiles are 
known, use:
x
Q M Q
≈
+ +1 3
3
Missing Mean: Online Resource
The online publication of15 links to an Excel spreadsheet which 
demonstrates the MQ1Q3 calculation to replace a missing mean, 
and does the same for simplified versions of methods MMM and 
MQ1Q3MM.
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